(0.24%) 5 074.50 points
(0.13%) 38 041 points
(0.35%) 17 721 points
(0.17%) $82.83
(2.22%) $1.750
(0.09%) $2 390.50
(0.40%) $28.52
(-0.70%) $947.50
(-0.01%) $0.937
(-0.08%) $10.98
(-0.09%) $0.802
(0.17%) $94.22
Live Chart Being Loaded With Signals
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases...
Stats | |
---|---|
Today's Volume | 10.42M |
Average Volume | 10.03M |
Market Cap | 0.00 |
EPS | $-0.200 ( 2021-11-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -13.32 |
ATR14 | $0.213 (2.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-11-09 | Waksal Harlan | Sell | 177 945 | Common Stock |
2021-11-09 | Waksal Harlan | Buy | 655 000 | Stock Appreciation Right |
2021-11-09 | Waksal Harlan | Buy | 982 500 | Performance Stock Option(right to buy) |
2021-11-09 | Waksal Harlan | Buy | 1 350 000 | Stock Option (right to buy) |
2021-11-09 | Waksal Harlan | Buy | 2 000 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 93 transactions |
Buy: 16 325 233 | Sell: 4 159 124 |
Volume Correlation
Kadmon Holdings Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kadmon Holdings Inc Correlation - Currency/Commodity
Kadmon Holdings Inc Financials
Annual | 2020 |
Revenue: | $8.29M |
Gross Profit: | $6.29M (75.86 %) |
EPS: | $-0.670 |
Q3 | 2021 |
Revenue: | $14.71M |
Gross Profit: | $14.06M (95.63 %) |
EPS: | $-0.200 |
Q2 | 2021 |
Revenue: | $197 000 |
Gross Profit: | $186 000 (94.42 %) |
EPS: | $-0.180 |
Q1 | 2021 |
Revenue: | $563 000 |
Gross Profit: | $467 000 (82.95 %) |
EPS: | $-0.170 |
Financial Reports:
No articles found.
Kadmon Holdings Inc
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. Its lead product candidates include KD025, an orally administered selective inhibitor of the rho-associated coiled-coil kinase 2, which is in Phase II clinical trial for the treatment of chronic graft-versus-host and fibrotic diseases; KD045, an oral inhibitor of ROCK for the treatment of fibrotic diseases; and KD033, an anti-PD-L1/IL-15 fusion protein for the treatment of cancer. The company also engages in developing Tesevatinib to treat autosomal dominant polycystic kidney disease; ribavirin, a nucleoside Inhibitor to treat hepatitis; and CLOVIQUE, a trientine hydrochloride capsules for the treatment of Wilson's disease. Kadmon Holdings, Inc. has strategic collaborations and license agreements with Nano Terra, Inc. and Dyax Corp. The company was founded in 2010 and is headquartered in New York, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators